For research and educational purposes only. Peptides are not approved for human use unless specifically indicated. Read full disclaimer.
PeptideHub
Stacks & combinations

CJC-1295 stacks: research-backed combinations

How CJC-1295 is combined in published protocols — the goal of each stack, the supporting research, and what to watch for.

Established CJC-1295 stacks

CJC-1295 / Ipamorelin

Goal: Synergistic, prolactin-sparing GH pulse

Combining a GHRH analog with a GHRP produces a larger GH pulse than either alone. Ipamorelin is selective and does not elevate cortisol or prolactin.

How to think about stacking

  • Mechanism diversity beats redundancy. Pairing compounds that hit different pathways usually outperforms stacking two compounds with similar mechanisms.
  • Track one variable at a time. Starting two peptides simultaneously makes it impossible to attribute effects. Research protocols typically introduce stacks sequentially.
  • Side-effect interactions. Some peptides compound each other's side effects (e.g., GLP-1 agonists with other GI-active compounds). Review side-effect profiles before stacking.

CJC-1295 stacks FAQ

Can CJC-1295 be stacked with other peptides?+

Yes — CJC-1295 is commonly stacked with Ipamorelin in research protocols.

What's the best CJC-1295 stack for recovery?+

CJC-1295 is not typically used as a primary recovery agent. Researchers studying recovery often anchor protocols on BPC-157 and TB-500.

Are peptide stacks safe?+

Stacking compounds the side-effect risks of each peptide. Most research-grade protocols stay within one or two peptides at a time and reassess after 4–8 weeks. This is not medical advice.